KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Cash from Operations: 2009-2025

Historic Cash from Operations for Cme Group (CME) over the last 16 years, with Sep 2025 value amounting to $968.1 million.

  • Cme Group's Cash from Operations fell 3.48% to $968.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 billion, marking a year-over-year increase of 11.95%. This contributed to the annual value of $3.7 billion for FY2024, which is 6.85% up from last year.
  • According to the latest figures from Q3 2025, Cme Group's Cash from Operations is $968.1 million, which was down 8.54% from $1.1 billion recorded in Q2 2025.
  • Cme Group's 5-year Cash from Operations high stood at $1.1 billion for Q1 2025, and its period low was $499.8 million during Q2 2021.
  • For the 3-year period, Cme Group's Cash from Operations averaged around $935.2 million, with its median value being $968.1 million (2025).
  • Over the last 5 years, Cme Group's Cash from Operations had its largest YoY gain of 102.83% in 2021, and its largest YoY loss of 49.35% in 2021.
  • Quarterly analysis of 5 years shows Cme Group's Cash from Operations stood at $668.3 million in 2021, then surged by 46.87% to $981.5 million in 2022, then climbed by 6.40% to $1.0 billion in 2023, then decreased by 2.53% to $1.0 billion in 2024, then fell by 3.48% to $968.1 million in 2025.
  • Its Cash from Operations stands at $968.1 million for Q3 2025, versus $1.1 billion for Q2 2025 and $1.1 billion for Q1 2025.